share_log

Benchmark Maintains Buy on Nutex Health, Lowers Price Target to $2.5

Benchmark Maintains Buy on Nutex Health, Lowers Price Target to $2.5

基準維持對Nutex Health的買入,將目標價下調至2.5美元
Benzinga ·  2023/05/17 08:18

Benchmark analyst Bill Sutherland maintains Nutex Health (NASDAQ:NUTX) with a Buy and lowers the price target from $3 to $2.5.

基準分析師比爾·薩瑟蘭維持Nutex Health(納斯達克股票代碼:NUTX)的買入,並將目標股價從3美元下調至2.5美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論